Skip to main content

Table 2 Patient characteristics

From: A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer

 

Number (Percent)

Median age (Range)

63(53–67)

 Gender

  Male

9(100.0)

 KPS score

  90

8(88.9)

  80

1(11.1)

 Segment

  Siewert II/III

4(44.4)

  Gastric

5(55.6)

 T stage

  T3

1(11.1)

  T4a

6(66.7)

  T4b

2(22.2)

 N stage

  N0

1(11.1)

  N1

6(66.7)

  N2

2(22.2)

 Clinical stage

  IIB

2(22.2)

  IIIA

4(44.4)

  IIIB

2(22.2)

  IIIC

1(11.1)